>
High-Level Sources: Covert War In US, Israeli & Foreign Intel Agencies, Behind Epstein Case...
Hegseth Hosts Netanyahu at the Pentagon, Says It Was an 'Honor' To Be Part of the War Agains
Saagar Enjeti on the Dangerous New Developments in Pam Bondi's Epstein Cover-Up
Does Elon Musk's Third Party Have a Prayer? Trump Is Not a Believer
Insulator Becomes Conducting Semiconductor And Could Make Superelastic Silicone Solar Panels
Slate Truck's Under $20,000 Price Tag Just Became A Political Casualty
Wisdom Teeth Contain Unique Stem Cell That Can Form Cartilage, Neurons, and Heart Tissue
Hay fever breakthrough: 'Molecular shield' blocks allergy trigger at the site
AI Getting Better at Medical Diagnosis
Tesla Starting Integration of XAI Grok With Cars in Week or So
Bifacial Solar Panels: Everything You NEED to Know Before You Buy
INVASION of the TOXIC FOOD DYES:
Let's Test a Mr Robot Attack on the New Thunderbird for Mobile
Facial Recognition - Another Expanding Wolf in Sheep's Clothing Technology
Business Insider reported on the company first, while admitting there is little to no evidence that the procedure actually works.
But that hasn't stopped Amborisa creator Jesse Karmazin, from accepting payments via PayPal for the procedure: he is charging $8,000 for one literĀ of young blood and $12,000 for two liters. Karmazin, who isn't a licensed medical practitioner, told reporters last year that he had hoped to open his first clinic in New York City by the end of 2018. New York City has eluded him and instead he has opened locations in places like Los Angeles, San Francisco, Tampa and Houston.
Just like Theranos, the company also performed its own clinical trial to figure out what the effects of blood swapping would be. These results haven't been made public, but Karmazin has called them "really positive".